- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (42)
- Timeline of Article Publication (30)
- Authors Evaluation (6)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3929)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2023 (publication date) through Oct 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qu WZ, Wang L, Chen JJ, Wang Y. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor. World J Gastroenterol 2023; 29(26): 4200-4213 [PMID: 37475847 DOI: 10.3748/wjg.v29.i26.4200] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4200.htm |
| Number | Citing Articles |
| 1 |
Andrew Bustamante, Stavroula Baritaki, Apostolos Zaravinos, Benjamin Bonavida. Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2. Cancers 2024; 16(18): 3180 doi: 10.3390/cancers16183180
|
| 2 |
Xianqun Ji, Yu Shang, Lin Tan, Yan Hu, Junjie Liu, Lina Song, Junyan Zhang, Jingxian Wang, Yingjian Ye, Haidong Zhang, Tianfang Peng, Peng An. Prediction of High-Risk Gastrointestinal Stromal Tumor Recurrence Based on Delta-CT Radiomics Modeling: A 3-Year Follow-up Study After Surgery. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241245698
|